Compound Detail
CHEMBL5583677
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5583677 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JVEMUHKZVXBOIF-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
365.4
MW (Da)
1.50
ALogP
7
HBA
2
HBD
100.5
PSA (Ų)
0.72
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.06
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Egl nine homolog 1 CHEMBL5697 | IC50 | 7.06 | 7.06 | 87.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Egl nine homolog 1 | IC50 | = | 87.0 | nM | 7.06 | Inhibition of PHD2 (unknown origin) preincubated for 30 mins followed by substra... | 38189253 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38189253 | 10.1021/acs.jmedchem.3c01932 | Egl nine homolog 1 | 1 |
Data from ChEMBL 36 via Core Engine